Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Variations in Kisspeptin Levels During Controlled Ovarian Hyperstimulation in Patients with Polycystic Ovary Syndrome and Their Relationship with Treatment Outcomes

  • By

  • Lu Han

  • Yiran Wang

  • Yueying Li

  • Xiaoyan Li

  • Jing Zhang

  • Yan Zhang

  • Mingfei Zhao

  • Haixia Chen

  • Huiying Zhang

  • Yingmei Wang

  • Fengxia Xue

  • Wenyan Tian

  • May 20, 2026

Share

Clinical Report: Variations in Kisspeptin Levels During COH in PCOS Patients

Overview

{'correlation': 'Specify the nature of the correlation between elevated Kisspeptin levels and treatment outcomes.'}

Background

{'neuroendocrine_mechanisms': "Expand on the neuroendocrine mechanisms involved in COH and Kisspeptin's role."}

Data Highlights

{'statistical_significance': 'Include significance values for all parameters in the data table.'}

Key Findings

{'clinical_context': 'Provide context on how the findings impact clinical practice.'}

Clinical Implications

{'research_needs': 'Highlight the necessity for further validation of Kisspeptin as a biomarker.'}

Conclusion

{'future_research': 'Suggest specific areas for future research on Kisspeptin and reproductive dysfunction.'}

Related Resources & Content

  1. Frontiers in Endocrinology, 2026 -- Assessment indicators of ovarian response during controlled ovarian stimulation: influencing factors and clinical value
  2. The Journal of Clinical Endocrinology & Metabolism, 2026 -- Kisspeptin Treatment Enhances Reproductive Hormone Levels Without Impacting Anxiety in Humans
  3. The Journal of Clinical Endocrinology & Metabolism, 2026 -- Elevated AMH Levels Correlate With Gestational Hypertension in PCOS Patients Undergoing IVF/ICSI with Fresh Embryo Transfer
  4. Frontiers, 2026 -- Dynamic Changes of Kisspeptin during Controlled Ovarian Hyperstimulation (COH) in Polycystic Ovary Syndrome Patients and Its Correlation with COH Outcomes
  5. The Journal of Clinical Endocrinology & Metabolism — Evaluation of Cumulative Live Birth Rates in Preimplantation Genetic Testing Cycles: Progestin Versus GnRH Analogues
  6. ESHRE Guidelines on Ovarian Stimulation
  7. Frontiers | Dynamic Changes of Kisspeptin during Controlled Ovarian Hyperstimulation (COH) in Polycystic Ovary Syndrome Patients and Its Correlation with COH Outcomes

Original Source(s)

Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes

  • by Lu Han, Yiran Wang, Yueying Li, Xiaoyan Li, Jing Zhang, Yan Zhang, Mingfei Zhao, Haixia Chen, Huiying Zhang, Yingmei Wang, Fengxia Xue, Wenyan Tian

  • May 20, 2026

Related Content

Editorial Expression of Concern: Office microlaparoscopic ovarian drilling (OMLOD) versus conventional laparoscopic ovarian drilling (LOD) for women with polycystic ovary syndrome

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

Adjunctive berberine improves hormonal, metabolic, and inflammatory profiles in women with polycystic ovary syndrome: a retrospective case–control study